Stühler V, Kruck S, Todenhöfer T, Stenzl A, Bedke J
Klinik für Urologie, Eberhard Karls Universität, Hoppe-Seyler-Str. 3, 72070, Tübingen, Deutschland.
Urologe A. 2018 Mar;57(3):300-306. doi: 10.1007/s00120-018-0586-6.
After surgical resection of renal cell carcinoma by laparoscopic or open partial or complete nephrectomy, medical aftercare based on the current guidelines should be provided. This seems desirable, especially because one third of patients after initial curative tumor resection develop recurrence over time. In this article, the current recommendations for follow-up will be systematically presented based on the accepted German S3 guideline and the European Association of Urology (EAU) guideline. Another point of this article will be the presentation of the currently applied risk scores to predict prognosis with a focus on molecular markers. The goal is to improve the prediction of survival and to facilitate risk-adjusted aftercare.
通过腹腔镜或开放手术进行部分或完全肾切除术后，应根据当前指南提供医学后续护理。这似乎是可取的，特别是因为三分之一的患者在最初的根治性肿瘤切除术后会随着时间的推移出现复发。在本文中，将根据公认的德国S3指南和欧洲泌尿外科学会（EAU）指南系统地介绍当前的随访建议。本文的另一个要点是介绍目前应用的风险评分，以预测预后，重点是分子标志物。目标是改善生存预测并促进风险调整后的后续护理。
